arrow
H

Hiddo J.L. Heerspink

university medical center groningen
H指数:118
被引数:6.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Acute eGFR Changes With Finerenone Examined in a Prespecified Analysis of FINE-ONE

在FINE-ONE研究的预设分析中考察非奈利酮引起的急性eGFR变化

2026-09-160
OAAI
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: insights from the CREDENCE trial

卡格列净在CKD患者中不同联合用药负担下的疗效和安全性具有一致性:来自CREDENCE试验的见解

2026-09-040
OAAI
Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis

非糖尿病性高血压慢性肾脏病患者中的非奈利酮:FIND-CKD亚组分析

2026-08-300
OAAI
Coordinated clinical trial networks in nephrology: strengthening research infrastructure and improving trial delivery

肾病领域协调的临床试验网络:加强研究基础设施和提高试验交付

2026-08-060
OA
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial

同时起始非奈利酮和恩帕格利福辛对白蛋白尿的影响:一项随机CONFIDENCE试验的参与者水平探索性分析,不考虑基线HbA1c水平

2026-08-050
OAAI
Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy on CKD progression

ZENITH高蛋白尿试验的设计和基线特征:评估zibotentan/dapagliflozin对CKD进展有效性的研究

2026-08-040
OAAI
Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials

糖尿病中降低白蛋白尿治疗对心血管预测性鞘脂的影响:ROTATE试验的事后分析

2026-07-310
OAAI
SGLT2 inhibition modulates metabolic; vascular; and inflammatory molecular markers in the kidney in youth with type 1 diabetes

SGLT2抑制剂调节1型糖尿病青少年肾脏中的代谢、血管和炎症分子标志物

2026-07-220
PRE
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals

在640万个人中预防和评分2心血管风险方程的跨国验证

2026-05-050
OAAI
Intra-Individual Variability of Urinary EGF and Clusterin, and Effect of Frozen Storage on Stability: Results from UVALID

尿液EGF和clusterin的个体内变异性及冷冻储存对其稳定性的影响:UVALID研究的结果

2026-04-270
OA
Recommendations for Pre-Analytical Urine Sample Handling To Allow Optimal Assessment of Albuminuria and Proteinuria A consensus report of the USA NKF Albuminuria – Proteinuria Workshop

关于优化评估尿微量白蛋白和蛋白尿的尿液样本前处理建议——美国肾脏基金会尿微量白蛋白-蛋白尿研讨会的共识报告

2026-04-240
OA
Effects of Semaglutide on Body Composition and GFR A Prespecified Analysis of the SMART Trial

司美格鲁肽对身体成分和GFR的影响:SMART试验的预先指定分析

2026-04-011
PRE